RetireReady NJ launched a pilot program in spring 2024 with four participating employers, and now it supports thousands of New Jersey employees in saving for retirement.
The American Diabetes Association has issued a guidance statement that cautions against using compounded versions of popular GLP-1 diabetes and weight-loss drugs such as Wegovy and Zepbound.
It’s a fair and reasonable ask of legislators to create parity of choice for retirement investors, regardless of who their employer is, according to collective trust provider Great Gray Trust Company.